Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Autor: Arachchillage, D.R.J. *, Mackie, I.J., Efthymiou, M., Chitolie, A., Hunt, B.J., Isenberg, D.A., Khamashta, M., Machin, S.J., Cohen, H.
Zdroj: In Journal of Thrombosis and Haemostasis November 2016 14(11):2177-2186
Databáze: ScienceDirect
Externí odkaz: